MIRA Pharmaceuticals, Inc. Common Stock (MIRA) — Financial Flexibility Index

Latest as of September 2025: -13.07x

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) has a Financial Flexibility Index of -13.07x as of September 2025. Free cash flow of $-1.10 Million (operating CF $-1.10 Million minus capex $4.00) represents -13% of total liabilities ($83.93K). Also explore MIRA Pharmaceuticals, Inc. Common Stock (MIRA) net asset momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-13.07x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-1.10 Million
Operating CF − Capex

Total Liabilities

$83.93K
USD

Capital Expenditures

$4.00
USD

MIRA Pharmaceuticals, Inc. Common Stock Financial Flexibility Index (2020–2024)

Historical Financial Flexibility Index trend for MIRA Pharmaceuticals, Inc. Common Stock across 5 annual periods. Check MIRA Pharmaceuticals, Inc. Common Stock (MIRA) strategic asset index to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for MIRA Pharmaceuticals, Inc. Common Stock (2020–2024)

Year-by-year free cash flow to debt coverage for MIRA Pharmaceuticals, Inc. Common Stock. For the full company profile including market capitalisation, see MIRA Pharmaceuticals, Inc. Common Stock stock valuation.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -7.69x $-5.56 Million $-5.56 Million $723.35K ▲ +5.3%
2023 -8.12x $-4.53 Million $-4.53 Million $558.10K ▼ -110.7%
2022 -3.85x $-5.60 Million $-5.60 Million $1.45 Million ▼ -206.3%
2021 -1.26x $-1.38 Million $-1.38 Million $1.09 Million ▼ -67.2%
2020 -0.75x $-67.99K $-67.99K $90.36K
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities